CNR2
CNR2, also known as CB2 and formerly named cannabinoid receptor 2 (macrophage), is a heterotrimeric G protein-coupled receptor for the endocannabinoid 2-arachidonoylglycerol. Its activation inhibits adenylate cyclase, and it has been linked to inflammatory response, nociceptive transmission and bone homeostasis. Browse Assay Genie's current range of CNR2 research reagents below, or read on for the biology behind the target.
CNR2 is a heterotrimeric G protein-coupled receptor (GPCR) for the endocannabinoid 2-arachidonoylglycerol. Ligand binding mediates inhibition of adenylate cyclase. According to RefSeq, this inhibition occurs in a dose-dependent, stereoselective and pertussis toxin-sensitive manner, which is characteristic of receptors coupled to inhibitory G proteins. UniProt annotates the receptor as one that may function in inflammatory response, nociceptive transmission and bone homeostasis.
The CNR2 gene encodes the cannabinoid receptor 2 protein, which belongs to the G protein-coupled receptor 1 family and is placed by HGNC in the cannabinoid receptors gene group. In cells, the protein is found at the cell membrane, and UniProt also records it in dendrites and the perikaryon. The mouse and rat orthologs are both named Cnr2, so the receptor can be studied in common rodent models.
CNR2 and the cannabinoid receptor 1 (brain) gene, CNR1, encode the two cannabinoid receptors described in the NCBI Gene summary. Both are GPCRs for cannabinoids, including delta-9-tetrahydrocannabinol, the principal psychoactive ingredient of marijuana. These proteins have been implicated in the cannabinoid-induced central nervous system effects, including alterations in mood and cognition, experienced by marijuana users. The alias CB2 is widely used in the literature, and the earlier HGNC name, cannabinoid receptor 2 (macrophage), is still found in older references.
CNR2 may function in inflammatory response, making it a receptor of interest for studying how endocannabinoid signalling shapes inflammatory processes.
UniProt notes a possible role for CNR2 in nociceptive transmission, which supports its study in pain signalling pathways.
CNR2 may function in bone homeostasis, so the receptor is relevant to work on how endocannabinoids influence bone biology.
As a Gi-type GPCR that inhibits adenylate cyclase, CNR2 is a model for studying endocannabinoid and cannabinoid receptor pharmacology alongside CNR1.
CNR2 is a G protein-coupled receptor for the endocannabinoid 2-arachidonoylglycerol. When activated it inhibits adenylate cyclase. UniProt reports that it may function in inflammatory response, nociceptive transmission and bone homeostasis, and it sits at the cell membrane.
Yes. CB2 is an alias for CNR2, and HGNC lists cannabinoid receptor 2 (macrophage) as a previous name. CNR1 encodes the related cannabinoid receptor 1 (brain). Both are family 1 GPCRs that inhibit adenylate cyclase and respond to cannabinoids.
Yes. Both the mouse and the rat have an ortholog named Cnr2, so the receptor can be studied in rodent models. Check the datasheet of any product for its validated reactivity.
The other cannabinoid receptor, CNR1, and related GPCR targets with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P34972; product specifications from Assay Genie datasheets.